NMRA-511
- Generic Name
- NMRA-511
Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
Phase 1
Recruiting
- Conditions
- Healthy ElderlyAlzheimer's Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- Neumora Therapeutics, Inc.
- Target Recruit Count
- 96
- Registration Number
- NCT06546995
- Locations
- 🇺🇸
Neumora Investigator Site, Mesquite, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath